African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
<h4>Background</h4>Onchocerciasis causes a considerable disease burden in Africa, mainly through skin and eye disease. Since 1995, the African Programme for Onchocerciasis Control (APOC) has coordinated annual mass treatment with ivermectin in 16 countries. In this study, we estimate the...
Guardado en:
Autores principales: | Luc E Coffeng, Wilma A Stolk, Honorat G M Zouré, J Lennert Veerman, Koffi B Agblewonu, Michele E Murdoch, Mounkaila Noma, Grace Fobi, Jan Hendrik Richardus, Donald A P Bundy, Dik Habbema, Sake J de Vlas, Uche V Amazigo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0496d73682e9493196fc9f9cc1a2feba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
por: Natalie V S Vinkeles Melchers, et al.
Publicado: (2021) -
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
por: Natalie V S Vinkeles Melchers, et al.
Publicado: (2021) -
Achieving herd immunity against COVID-19 at the country level by the exit strategy of a phased lift of control
por: Sake J. de Vlas, et al.
Publicado: (2021) -
Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study.
por: Méba Banla, et al.
Publicado: (2014) -
Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning.
por: Elizabeth A Cromwell, et al.
Publicado: (2021)